Shares of Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) have been given a consensus recommendation of “Hold” by the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, two have assigned a hold recommendation and two have given a buy recommendation to the company.
Several equities analysts have commented on SAUHY shares. Barclays reissued an “overweight” rating on shares of Straumann in a research report on Thursday. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research report on Tuesday, April 14th. Finally, Citigroup reissued a “sell” rating on shares of Straumann in a research report on Thursday, April 23rd.
Check Out Our Latest Stock Analysis on Straumann
Straumann Price Performance
Straumann Company Profile
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Further Reading
- Five stocks we like better than Straumann
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
- Can Trupanion Turn Pet Insurance Loyalty Into Real Earnings?
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
